Introduction

30
Population demographics in both developed and developing countries is shifting towards a 31 population with a higher proportion of people aged 65 years of age and above (Stegemann et 
39
The increase in the likelihood of acquiring chronic diseases with age and resultant 40 polypharmacy increases the risk of non-adherence (Murray et al., 2004) , with unwanted 41 clinical and economic consequences. It is imperative that patients adhere to their treatment 42 regimen to achieve therapeutic goals. Adherence rates in the elderly are variable; but, as the 43 amount of medicines taken and the complexity of the regimen increases, the adherence rate 44 potentially decreases (Miller, 2008) . Furthermore, adherence and ability to manage medicines and number of participants, sampling and recruitment, and methodology was also recorded on 106 a data extraction sheet, which was developed by and reviewed within the research team. 
Eligibility criteria
Results
120
3.1.Search results
121
The total of 2657 citations were retrieved from searching the databases. A search using
122
Google UK and Google Australia yielded 4 further studies that also met the inclusion criteria, 
168
Caregivers also felt that Scheduling logistics was a daily stress, with the most common to overcome these challenges and to ensure that medicines were available for the PLWD and 180 were given in a timely manner. One study focused on the factors affecting the decision to administer PRN medicines to 222 residents with dementia by paid carers in care homes (Carder, 2012) and found that the 
3.6.Theme 4: impact on PLWD
282
The PLWD is central to any discussion on challenges to medicines management; the 
3.7.Theme 5: partnership between caregiver and PLWD
304
The partnership between the caregiver and the PLWD is crucial to medicines use. Some 
Recommendations to improve medicines use in PLWD
356
The studies all provided recommendations for improvements from the participants, the 
Discussion
400
This review has shown that some data is available on the challenges in regard to medication 401 management and administration in older people. However, not all studies were exclusive to a 402 dementia population; some included a wider sample of older people, some of whom had The degree of cognitive impairment is a major issue and affects various activities, including 
Implications for research
490
This review has shed light on some gaps in knowledge, which includes how PLWD and their 491 caregivers cope with deteriorating cognitive impairment and other physical difficulties that 492 arise due to the progression of dementia that might affect how medicines are used. 
Limitations
507
This review does not include many studies, but this may be attributed to the specificity of the 508 research question. Furthermore, this highlights that this topic may not be well-researched.
509
Some of the findings included were from conference abstracts; although the findings may not 510 always be as comprehensively peer-reviewed as journal articles, they widen the scope of the 511 issues. Many of the studies had small sample sizes; this can be due to the qualitative methods 
Conclusion
515
Dementia is a debilitating syndrome that affects both the patient and their caregiver, and the 516 number of people suffering from it will steadily increase as the population is ageing.
517
Although much work has been done to raise awareness of dementia, the focus has been on its To explore the views on dementia medicines from PLWD in the early stage of the condition, their main caregiver and their prescriber over time. 
Interviews, observation
Grounded theory To explore care home staff members' decision-making process to administer PRN medications to residents with dementia
